Altimmune Inc.
🏢 View company profile →12Patents
12Active
12Granted
47Portfolio score
Filing activity: Mar 21, 2012 → Jun 9, 2021
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9855328B2 | Immunization of avians by administration of non-replicating vectored vaccines | Emerging Cross-Sectional Technologies | 4 | Active |
| US9605275B2 | Rapid and prolonged immunologic-therapeutic | Emerging Cross-Sectional Technologies | 3 | Active |
| US11541028B2 | Peptide pharmaceuticals for treatment of NASH and other disorders | Human Necessities | 3 | Active |
| US9175310B2 | Rapid and prolonged immunologic-therapeutic | Emerging Cross-Sectional Technologies | 3 | Active |
| US9968667B2 | Targets and compositions for use in decontamination, immunoprophylaxis, and post-exposure therapy against anthrax | Chemistry; Metallurgy | 1 | Active |
| US11382968B2 | Coronavirus immunogenic compositions and uses thereof | Chemistry; Metallurgy | 1 | Active |
| US10183069B2 | Rapid and prolonged immunologic-therapeutic | Chemistry; Metallurgy | 1 | Active |
| US11040099B2 | Rapid and prolonged immunologic therapeutic | Chemistry; Metallurgy | 0 | Active |
| US11395802B2 | Biodegradable polymeric particles encapsulating an active agent, pharmaceutical compositions and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US11040100B2 | Rapid and prolonged immunogic therapeutic | Chemistry; Metallurgy | 0 | Active |
| US10744195B2 | Immunization of avians by administration of non-replicating vectored vaccines | Emerging Cross-Sectional Technologies | 0 | Active |
| US11141477B2 | Rapid and prolonged immunologic-therapeutic | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.